Pancreatic cancer is the third most common cause of cancer-related death in the US. Most common presentation is at 65 to 75 years of age with painless obstructive jaundice and weight loss. Generally presents late with advanced disease. Surgical resection offers the only hope for cure.

Ducreux M, Cuhna AS, Caramella C, ESMO Guidelines Committee: Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26 (suppl 5):v56-v68, 2015. 5. Khorana AA, Mangu PB, Berlin J, et al: Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2015) The guideline (updates) are used to present the latest information on pancreatic cancer including recommendations for screening and diagnosis, along with stage-matched therapeutic strategies. The guidelines can also address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Multidisciplinary panels of experts, including patient advocates, develop ASCO's clinical practice guidelines. Learn more about how advocates help create guidelines on the Cancer.Net Blog. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up† The major histological type of pancreatic cancer is ductal pancreatic adenocarcinoma accounting for >80% of pancreatic neoplasms. Other types are acinar cell carcinoma or Clinical practice guidelines (CPGs) play an important role in health care. The guideline development process should be precise and rigorous to ensure that the results are reproducible and not vague. To determine the quality of guidelines, the Appraisal of Guidelines and Research and Evaluation Start studying ESMO Pancreatic Cancer. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Search. Create.